Caffeine and cardiovascular aging: exploring sex-specific impacts on risk and arrhythmias

Abstract

Caffeine is a widely consumed stimulant known for its cardiovascular and metabolic effects. However, its impact on cardiovascular risk, including arrhythmias, in older adults remains underexplored. Emerging evidence highlights sex-specific differences in caffeine metabolism, which may influence its role in cardiovascular health. This perspective examines the interaction between caffeine, hormonal changes, metabolic processes, and lifestyle factors, focusing on older women compared to men. Understanding these differences is essential for tailoring dietary and clinical recommendations to mitigate cardiovascular risks and promote healthy aging.

Aging introduces significant changes in cardiovascular health, with an increased prevalence of hypertension, arrhythmias, and other cardiovascular diseases (CVD).^[1] Caffeine, a commonly consumed stimulant, affects cardiovascular physiology by modulating heart rate (HR), blood pressure (BP), and vascular tone. These effects are mediated by adenosine receptor antagonism and alterations in sympathetic nervous system activity.^[2,3]

Despite its widespread consumption, the cardiovascular effects of caffeine, particularly in older adults, remain complex and sometimes contradictory. Some studies suggest a protective role against CVD, while others raise concerns about its potential to induce arrhythmias or exacerbate existing conditions.^[4,5] Sex-specific differences in caffeine metabolism and cardiovascular responses further complicate these findings, necessitating a closer examination of caffeine’s impact on cardiovascular health in aging populations.

SEX-SPECIFIC METABOLISM OF CAFFEINE

Caffeine exerts its cardiovascular effects via adenosine receptor antagonism, phosphodiesterase inhibition, and increased sympathetic nervous system activation. These mechanisms lead to elevated HR and BP due to increased catecholamine release.^[2,3] Caffeine metabolism primarily occurs in the liver via the cytochrome P450 enzyme 1A2 (CYP1A2), which is responsible for over 90% of caffeine clearance through demethylation pathways.^[6,7] However, CYP1A2 activity is sexually dimorphic, influenced by both genetic factors and hormonal modulation. Studies have shown that premenopausal women exhibit lower CYP1A2 activity compared to men due to the inhibitory effects of estrogen and progesterone on enzyme expression.^[8,9]

During pregnancy, caffeine metabolism is further slowed as CYP1A2 activity decreases by up to 65% by the third trimester, leading to prolonged caffeine half-life and greater systemic exposure.^[10] Estrogen modulates vascular reactivity by upregulating nitric oxide production, which counterbalances caffeine-induced vasoconstriction. However, excessive caffeine intake may override these protective mechanisms, exacerbating vascular stress and increasing the risk of preeclampsia and gestational hypertension.^[11]

Oral contraceptive use similarly reduces CYP1A2-mediated clearance, indicating hormonal influence beyond pregnancy.^[12]

These metabolic differences prolong caffeine’s physiological effects in women, increasing the risk of hypertension, endothelial dysfunction, and fetal growth restriction in pregnant women who consume high doses of energy drinks.^[13,14]

Caffeine metabolism differs between older women and men due to hormonal and physiological changes associated with aging. Estrogen plays a key role in regulating CYP1A2 activity, hereby slowing caffeine clearance in premenopausal women.^[9] In contrast, the decline in estrogen levels after menopause accelerates caffeine metabolism, potentially diminishing its cardiovascular effects. These hormonal shifts influence caffeine’s impact on HR variability (HRV) and may reduce its protective effects against arrhythmias.^[15]

Estrogen upregulates endothelial nitric oxide synthase, leading to increased production of nitric oxide, which is a potent vasodilator that regulates BP and enhances endothelial function.^[15] This vasodilatory action counteracts caffeine-induced vasoconstriction, which occurs through adenosine receptor antagonism and sympathetic nervous system activation, both of which contribute to elevated vascular resistance and increased BP.

In premenopausal women, estrogen helps mitigate caffeine’s hypertensive effects by preserving nitric oxide-mediated vasodilation, thereby stabilizing HRV and lowering the risk of arrhythmias.^[16] However, as estrogen levels decline in postmenopausal women, endothelial nitric oxide synthase activity and nitric oxide bioavailability are reduced, leading to impaired vascular relaxation. This hormonal shift increases sensitivity to vasoconstrictive stimuli, reducing the body’s ability to counteract caffeine’s pressor effects and potentially increasing susceptibility to hypertension and cardiovascular dysfunction.^[16–18]

Additionally, the decline in estrogen post-menopause enhances CYP1A2 activity, leading to faster caffeine metabolism and clearance, resulting in a shorter duration of caffeine’s cardiovascular effects. Consequently, caffeine may exert a less pronounced impact on BP and HR regulation in postmenopausal women compared to their premenopausal counterparts.^[3,8,9,19]

In contrast, older men, with relatively stable hormonal profiles, demonstrate more consistent caffeine metabolism. Testosterone’s limited interaction with CYP1A2 activity allows caffeine’s cardiovascular effects, such as improved endothelial function and reduced arterial stiffness, to remain relatively uniform across age groups.^[9,20] These sex-specific differences in metabolism highlight the need for individualized approaches to caffeine consumption in older adults.

While CYP1A2 is the major enzyme responsible for caffeine clearance, other metabolic pathways and enzymes contribute to its breakdown, influencing individual responses to caffeine consumption.^[2,3] Once ingested, caffeine is rapidly absorbed in the gastrointestinal tract, reaching peak plasma concentrations within 30–120 min. The liver is the primary site of metabolism, where caffeine undergoes a series of transformations to form three major metabolites: paraxanthine (80%), theobromine (10%), and theophylline (4%). Paraxanthine, the most abundant metabolite, enhances lipolysis and contributes to caffeine’s stimulatory effects, while theobromine, commonly found in cocoa, has vasodilatory properties. Theophylline, though present in smaller amounts, has been studied for its bronchodilator effects, particularly in respiratory conditions like asthma.^[21]

CYP1A2 is responsible for over 90% of caffeine metabolism and other enzymes, such as xanthine oxidase, N-acetyltransferase 2 (NAT2), and uridine 5’-diphospho-glucuronosyltransferase, contribute to its breakdown and excretion. Variations in these enzymes can lead to significant differences in caffeine metabolism between individuals. For instance, xanthine oxidase facilitates the conversion of caffeine metabolites into uric acid derivatives, influencing their elimination. Similarly, NAT2 is involved in acetylation, and individuals with slower NAT2 activity may experience prolonged caffeine effects. Additionally, uridine 5’-diphospho-glucuronosyltransferase enzymes play a role in conjugating caffeine metabolites with glucuronic acid, aiding in renal excretion. These alternative pathways highlight that caffeine metabolism is not solely dependent on CYP1A2 activity but is instead a multifaceted process with significant individual variability.^[2,3,21,22]

Beyond enzymatic metabolism, recent research has uncovered the influence of gut microbiota on caffeine metabolism.^[23] Some bacterial species, such as Bacteroides and Firmicutes phyla, have been shown to metabolize caffeine and its derivatives. Some bacteria, such as Pseudomonas putida and Acinetobacter, possess enzymes capable of demethylating caffeine, effectively reducing its bioavailability and altering its physiological effects. Furthermore, gut microbiota-derived metabolites, including short-chain fatty acids, have been found to modulate liver enzyme activity, potentially influencing CYP1A2 expression and overall caffeine metabolism.^[23]

The relationship between gut microbiota and caffeine metabolism extends beyond direct microbial degradation. Dysbiosis, or an imbalance in gut microbial composition, can lead to systemic inflammation, which may impair liver enzyme function and, consequently, affect caffeine clearance. This interaction suggests that factors such as diet, antibiotic use, and lifestyle choices that influence gut microbiota composition could indirectly shape an individual’s response to caffeine.^[24,25] A cross-sectional study by Dai, et al.^[26] found that the colonic mucosa-associated bacteria differed significantly in the community composition and structure based on daily caffeine and coffee intake in adults.

These metabolic complexities have significant clinical implications, particularly in older adults, where enzyme activity and gut microbiota composition may change with age. The interplay between caffeine metabolism, genetic predisposition, and microbiome diversity suggests that caffeine’s cardiovascular effects can vary widely among individuals.^[27] Therefore, a more personalized approach to caffeine consumption may be needed, taking into account not only CYP1A2 activity but also other metabolic pathways and the balance of the gut microbiota, particularly in patients at cardiovascular risk.

INFLAMMAGING AND CARDIOVASCULAR AGING

Aging is associated with a chronic, low-grade inflammatory state known as inflammaging, which contributes to endothelial dysfunction, arterial stiffness, and increased cardiovascular risk.^[28–30]

Inflammaging results from immune dysregulation, oxidative stress, and the accumulation of cellular damage over time. Elevated levels of pro-inflammatory cytokines such as interleukin-6, tumor necrosis factor-alpha, and C-reactive protein have been linked to an increased risk of hypertension, arrhythmias, and CVD.^[29,31] Caffeine’s impact on inflammaging is complex. Coffee contains polyphenols and antioxidants, which can prevent oxidative stress and inflammation.^[32,33] However, excessive caffeine consumption may stimulate the release of catecholamines, exacerbating inflammatory pathways and potentially worsening vascular aging. Furthermore, caffeine influences autophagy and mitochondrial function, which are critical in aging and inflammation regulation.^[34] In postmenopausal women, the loss of estrogen amplifies inflammaging, leading to higher oxidative stress and vascular inflammation. While moderate coffee intake may offer protective effects against age-related inflammation, high doses may promote inflammatory responses, especially in individuals with pre-existing conditions such as hypertension or metabolic syndrome.^[17]

EFFECTS OF CAFFEINE ON ARRHYTHMIAS

Mechanisms Underlying Caffeine-induced Arrhythmias

Excessive caffeine consumption may have potential proarrhythmic effects due primarily to key mechanisms including adenosine receptor antagonism, phosphodiesterase inhibition calcium overload, and increased sympathetic nervous system activity.^[2,3,35,36]

Caffeine has various biochemical targets and different mechanisms that exert its effects, including adenosine receptor antagonism, calcium mobilization, and catecholamine release.

Adenosine slows the sinoatrial node, reducing the HR and preventing excessive excitability. It also slows electrical conduction through the atrioventricular node. Caffeine blocks adenosine receptors, increasing the electrical excitability of the heart. The sinoatrial node fires more rapidly, increasing the HR, while the atrioventricular node allows electrical signals to pass unchecked, potentially triggering supraventricular tachycardia or even atrial fibrillation (AF). In healthy individuals, this effect may be subtle, but in those with underlying heart conditions, such as atrial fibrosis or hypertension, this increased excitability can significantly increase arrhythmic risk.^[35,36]

In addition to its effect on adenosine, caffeine also acts on calcium management system. When caffeine is consumed in large amounts, it increases the release of calcium from storage sites within cells, while also inhibiting enzymes that normally help regulate calcium levels. This calcium overload can lead to afterdepolarizations. If these impulses occur early in repolarization, they can trigger torsades de pointes.^[37] If they occur later, they can cause ectopic beats that can progress to AF or ventricular tachycardia. This effect is especially concerning for individuals with underlying heart disease because they are already more vulnerable to electrical instability. In addition to its direct effects on the cardiomyocyte, caffeine stimulates the sympathetic nervous system by increasing adrenaline and noradrenaline. This adrenaline rush increases HR and BP. In regular coffee drinkers, this increased stimulation is attenuated.^[38] However, for individuals with hypertension, coronary artery disease, or a history of arrhythmias, this heightened state of alertness can create electrical chaos. The refractory period of the cells becomes shorter, exposing the subject to reentry arrhythmias, which cause AF or even ventricular arrhythmias.^[35]

The combination of adenosine blockade, calcium overload, and sympathetic activation creates the perfect storm for arrhythmias, especially in individuals with preexisting cardiovascular conditions. While a cup or two of coffee may not pose a significant risk for most people, excessive caffeine intake, especially from energy drinks or highly concentrated sources, can lead to dangerous rhythm disturbances.

Despite these assumptions, clinical studies suggest that caffeine may reduce the risk of AF and other arrhythmias in moderate doses due to its antioxidant properties and positive effects on endothelial function.^[8,39] One contributing factor is coffee’s ability to lower blood uric acid levels, which may otherwise exhibit proarrhythmic properties.^[40] However, excessive caffeine consumption can induce palpitations and increase susceptibility to arrhythmias in sensitive individuals, especially those with pre-existing cardiovascular conditions.^[41,42] Additionally, caffeine’s effect on calcium metabolism in postmenopausal women raises concerns about its long-term impact on vascular calcification and arterial stiffness, which are critical determinants of cardiovascular risk.^[43] In older men, caffeine’s cardiovascular effects are generally more favorable, including reduced arterial stiffness and improved myocardial efficiency. However, high doses may exacerbate arrhythmic potential through increased sympathetic activation, particularly during stress or physical exertion.^[44,45] Men’s higher baseline cardiovascular fitness and lean mass could mitigate some adverse effects, but individual variability remains significant.

Clinical Studies on Caffeine and Arrhythmias

Caffeine’s long-term impact on cardiovascular risk and arrhythmias, particularly in older adults, presents a balance of potential benefits and risks. While moderate caffeine consumption has been associated with protective cardiovascular effects, concerns persist regarding its role in arrhythmia development, especially in high-risk populations.

A recent retrospective analysis of the National Health and Nutrition Examination Survey (NHANES) cohort examined the association between caffeine intake and all-cause and cardiovascular mortality in elderly hypertensive patients. The study found that moderate caffeine intake (200–300 mg/day) was linked to a lower risk of all-cause mortality (HR = 0.70, 95% CI: 0.56–0.87) and cardiovascular mortality (HR = 0.55, 95% CI: 0.39–0.77). Interestingly, the protective effect on all-cause mortality was significant in female patients (HR = 0.65, 95% CI: 0.50–0.85) and in those with well-controlled BP (HR = 0.63, 95% CI: 0.46–0.87), but it did not extend to male patients or individuals with poorly controlled hypertension.^[46]

Similarly, a 12-year unselected population cohort study of 1475 men and women conducted by Casiglia, et al.^[47] demonstrated that higher caffeine intake was associated with a lower incidence of AF. The incidence of AF was significantly lower in the third tertile of caffeine consumption (2.2%) compared to the first (10.2%) and second (5.7%) tertiles (P < 0.001). Their findings suggest that caffeine intake exceeding 320 mg/day may be inversely correlated with AF risk in the general population.

Additionally, a large-scale UK Biobank study evaluating coffee subtype consumption found that ground and instant coffee (but not decaffeinated coffee) was associated with a significant reduction in arrhythmia risk at moderate intake levels. The lowest risk was observed at 4–5 cups/day for ground coffee (HR = 0.83, 95% CI: 0.76–0.91, P < 0.0001) and 2–3 cups/day for instant coffee (HR = 0.88, 95% CI: 0.85–0.92, P < 0.0001). Importantly, all coffee subtypes, including decaffeinated coffee, were associated with a reduction in CVD risk and all-cause mortality. The greatest reduction in all-cause mortality was seen with 2–3 cups/day of decaffeinated (HR = 0.86, 95% CI: 0.81–0.91, P < 0.0001), ground (HR = 0.73, 95% CI: 0.69–0.78, P < 0.0001), and instant coffee (HR = 0.89, 95% CI: 0.86–0.93, P < 0.0001).^[48]

However, caffeine has been linked to increased susceptibility to arrhythmias, particularly AF and ventricular arrhythmias, due to its pharmacological effects on adenosine receptors and catecholamine release.^[35]

The activation of the sympathetic nervous system, particularly with high coffee consumption, has been associated with an increased risk of arrhythmias.

Research on caffeine’s electrophysiological effects has shown that it has minimal impact on refractory periods; however, at concentrations of 10 μM, caffeine increases spatial dispersion of repolarization, a phenomenon that can amplify its proarrhythmic potential and promote re-entry arrhythmias.^[49]

Additionally, catecholamine-induced activity has been suggested as a key mechanism underlying caffeine-related arrhythmias. Caffeine enhances catecholamine release and increases myocardial sensitivity to dopamine. Furthermore, by inhibiting phosphodiesterase, caffeine raises intracellular cyclic adenosine monophosphate levels, intensifying catecholamine-mediated cardiac stimulation, which may contribute to arrhythmogenesis.^[50]

Caffeine is generally considered a potential trigger for cardiac arrhythmias in clinical practice. High-dose caffeine has been shown experimentally to induce ventricular tachyarrhythmias and deaths.^[51]

Caffeine intoxication symptoms might resemble those of affective disorders, including anxiety.^[52] When it comes to caffeine intake, athletes, mental health sufferers, and infants should all be given special consideration. Athletes use large amounts of caffeine to help them perform and project a positive image. However, because caffeine interacts with many psychiatric medications, its use in patients with mental illnesses should be regarded as a significant risk factor for potential intoxications. Lastly, it has been determined that infants are the final group of individuals for whom caffeine usage should be strictly avoided.^[52,53]

A study on stimulant use among older adults indicated an early increase in cardiovascular events, including ventricular arrhythmias, following stimulant initiation, highlighting potential risks associated with caffeine consumption in this demographic.^[54]

In contrast, while caffeine may pose arrhythmia risks, its moderate consumption appears beneficial for cardiovascular health in older adults, suggesting a complex relationship that warrants further investigation.

CAFFEINE'S INTERACTION WITH CARDIOVASCULAR MEDICATIONS IN OLDER ADULTS

Older adults frequently manage cardiovascular conditions such as hypertension, AF, and coronary artery disease with pharmacological treatments, including beta-blockers, anticoagulants, and antihypertensive drugs. Given the widespread consumption of caffeine, understanding its potential interactions with these medications is crucial for optimizing treatment outcomes and minimizing adverse effects. However, these effects are attenuated in subjects who regularly consume coffee and caffeine due to the onset of tachyphylaxis.^[3,38,55]

Beta-blockers are commonly prescribed to reduce HR and BP by inhibiting beta-adrenergic receptors. Caffeine, as an adenosine receptor antagonist, exerts sympathomimetic effects by stimulating catecholamine release and increasing HR. This opposing action can attenuate the therapeutic effect of beta-blockers, potentially reducing their ability to control HR and BP, particularly in individuals with arrhythmias or hypertension.^[56]

Medved, et al.^[57] described a case of a 40-year-old male patient, with a history of schizophrenia and heavy caffeine and nicotine use, treated for acute psychotic episode with haloperidol and clozapine. Propranolol was administered because of clozapine-induced tachycardia. After 8 weeks without therapeutic response, the patient was referred for standard electroconvulsive therapy procedure, which included premedication and bifrontotemporal stimulation. After procedure patient developed Takotsubo cardiomyopathy. Some studies suggest that patients who consume high doses of caffeine while on beta-blockers may experience increased variability in BP and HR, leading to suboptimal cardiovascular control. According to Teramoto, et al.,^[58] heavy coffee consumption was associated with an increased risk of CVD mortality among people with severe hypertension, but not people without hypertension and with grade 1 hypertension.

Caffeine has well-documented pressor effects, with studies indicating that acute caffeine consumption can elevate systolic and diastolic BP, particularly in caffeine-naive individuals.^[59,60] This effect raises concerns for individuals on antihypertensive medications, including calcium channel blockers, angiotensin-converting enzyme inhibitors, and diuretics. Caffeine-induced vasoconstriction may counteract the vasodilatory effects of these drugs, reducing their efficacy in lowering BP. Moreover, habitual caffeine consumption may lead to tolerance over time, altering the degree to which caffeine impacts BP regulation in hypertensive patients. Importantly, the interaction between caffeine and diuretics may contribute to fluid and electrolyte imbalances, which can further complicate BP management.^[61]

Anticoagulants, including warfarin, direct oral anticoagulants (such as rivaroxaban and apixaban), and antiplatelet agents like aspirin and clopidogrel, are widely used in older populations to prevent thromboembolic events. Caffeine has been reported to influence platelet aggregation and fibrinolysis, potentially affecting clotting dynamics.^[62] Some research suggests that caffeine may enhance platelet aggregation inhibition, which could theoretically increase bleeding risk in patients on anticoagulant therapy.^[63] Additionally, caffeine metabolism occurs through the CYP1A2 enzyme, which is also involved in the metabolism of warfarin. Variability in CYP1A2 activity due to genetic polymorphisms or drug interactions could lead to altered warfarin clearance, affecting the international normalized ratio stability and increasing the risk of either thrombotic or hemorrhagic complications.^[64–66]

Given the high prevalence of polypharmacy in elderly patients, healthcare providers should be aware of these potential interactions when advising on caffeine consumption. While moderate caffeine intake is generally considered safe, patients on beta-blockers, anticoagulants, or antihypertensive medications should be counseled on possible interactions and individual variability in response.

LIFESTYLE FACTORS AND BEHAVIORAL DIFFERENCES

Caffeine consumption and its effects on cardiovascular risk and arrhythmias are influenced by a myriad of lifestyle factors, including physical activity levels, dietary preferences, and social behaviors.^[67] These factors modulate how caffeine interacts with cardiovascular physiology, particularly in older adults. Understanding these lifestyle influences is essential for tailoring recommendations to minimize risks and enhance benefits.

Physical Activity

Physical activity plays a crucial role in modulating caffeine’s cardiovascular effects. Caffeine is widely recognized for its ability to enhance endurance, increase energy availability, and improve myocardial efficiency during exercise. Studies have shown that moderate caffeine intake before physical activity reduces perceived exertion, enhances oxygen uptake, and promotes vasodilation, all of which are beneficial for cardiovascular health.^[68,69] For older adults, particularly women, lower levels of physical activity may limit these benefits.^[70] Women are less likely than men to engage in high-intensity exercise, a factor that could reduce caffeine’s impact on improving endothelial function and HRV.^[71] Pairing caffeine intake with tailored exercise interventions, such as walking or moderate-intensity aerobic activities, could help older women maximize caffeine’s cardiovascular advantages while minimizing the risk of arrhythmias. In men, higher engagement in high-intensity physical activity amplifies caffeine’s cardiovascular benefits, such as improved stroke volume and reduced arterial stiffness. However, this heightened activity may also increase susceptibility to exercise-induced arrhythmias when caffeine doses are excessive or when underlying cardiovascular conditions are present. Thus, careful moderation is essential.^[72,73]

Dietary Patterns

Dietary sources and consumption patterns of caffeine influence its cardiovascular effects. For older adults, coffee remains the primary source of caffeine. Coffee is rich in antioxidants like chlorogenic acid, which may provide additional protective effects against CVDs, including reducing inflammation and improving endothelial function.^[32,74]

However, men are more likely to consume caffeine from energy drinks and supplements, which often contain high levels of sugar and other stimulants. These additives can exacerbate insulin resistance, increase HR, and elevate BP, potentially offsetting caffeine’s cardiovascular benefits and heightening the risk of arrhythmias.^[75,76] Conversely, women often combine caffeine consumption with milk or plant-based alternatives, which may attenuate caffeine’s absorption but provide added benefits such as calcium or vitamin D. The dilution effect of milk in coffee could reduce the acute cardiovascular response to caffeine, potentially offering a protective buffer against arrhythmias.^[77,78]

Social and Cultural Habits

Social and cultural contexts shape caffeine consumption behaviors and their cardiovascular implications. Women tend to consume caffeine in moderate amounts during social activities, such as gatherings with friends or family. This pattern of consistent but lower-dose consumption may help mitigate the development of caffeine tolerance and reduce the risk of adverse cardiovascular events.^[79–81] Men, on the other hand, are more likely to consume caffeine for its performance-enhancing effects during targeted activities, such as workouts or long work hours. This behavior often involves higher doses of caffeine, which can lead to transient increases in BP and HR. While these effects are typically short-lived, repeated high-dose consumption may contribute to long-term cardiovascular strain.^[61,82]

Cultural practices also play a role. For instance, region with strong tea-drinking traditions may experience fewer caffeine-related cardiovascular issues due to the lower caffeine content in tea compared to coffee or energy drinks. In contrast, countries with a high prevalence of energy drink consumption may observe increased arrhythmias and hypertension rates, particularly among younger men who combine caffeine with other stimulants.^[83]

Sleep and Recovery

Caffeine’s stimulant properties can disrupt sleep patterns, especially when consumed later in the day. Poor sleep quality is a significant risk factor for CVDs and arrhythmias, as it impacts HRV, BP regulation, and overall cardiac function.^[84] Older adults, who are already prone to sleep disturbances, may experience amplified cardiovascular risks when caffeine consumption interferes with rest and recovery. To mitigate these effects, timing caffeine intake earlier in the day and opting for moderate doses can help preserve sleep quality while still providing its cardiovascular benefits. Women, who are more likely to consume caffeine socially, may already adhere to these practices, while men consuming caffeine for performance enhancement late into the evening might require more focused guidance.^[85]

Understanding these lifestyle factors provides a foundation for tailoring caffeine recommendations to older adults, with an emphasis on sex-specific needs and behaviors.

RESEARCH GAPS AND FUTURE DIRECTIONS

Caffeine’s cardiovascular effects have been extensively studied, but significant gaps remain in understanding its sex-specific impacts, especially in older adults. These differences are shaped by hormonal shifts, lifestyle factors, and varying physiological responses to caffeine. Addressing these gaps could pave the way for personalized dietary and clinical recommendations, improving cardiovascular outcomes while minimizing risks.

One pressing area of research involves the long-term effects of caffeine on HRV and arrhythmias in postmenopausal women. The hormonal landscape of women changes dramatically after menopause, with declining estrogen levels influencing cardiovascular function and caffeine metabolism. HRV, a key marker of autonomic nervous system health, often declines with age, correlating with increased risks of arrhythmias and CVD. Caffeine’s role as an adenosine receptor antagonist could affect HRV differently in postmenopausal women, potentially either stabilizing autonomic function at moderate doses or exacerbating risks at higher intakes. Current research provides only a fragmented understanding of this dynamic, underscoring the need for long-term studies focused on caffeine’s impact on HRV and arrhythmias in this vulnerable population.^[45]

Another intriguing avenue lies in examining the cardiovascular impact of different caffeine sources. While coffee, tea, and energy drinks all deliver caffeine, they come with distinct bioactive compounds that can amplify or mitigate its effects. For example, coffee’s antioxidant-rich profile might protect against inflammation and oxidative stress, supporting cardiovascular health.^[39] On the other hand, energy drinks, often consumed by men, frequently contain high levels of sugar, taurine, and other stimulants. These additives can elevate BP, increase HR, and raise arrhythmic potential, especially when consumed in excess or combined with physical exertion.^[85] Comparatively, tea, with its lower caffeine content and high levels of catechins, may offer a gentler cardiovascular effect, making it a potentially safer alternative for older adult.^[85]

These gaps highlight the need for nuanced research to clarify caffeine’s diverse effects across populations. Longitudinal studies that account for sex, age, medication use, and caffeine source could provide much-needed clarity. By exploring these areas, researchers can move closer to formulating evidence-based recommendations tailored to the unique cardiovascular needs of older adults, ensuring that caffeine consumption supports, rather than compromises, their health.

CONCLUSIONS

Caffeine’s effects on cardiovascular health are influenced by sex, age, and lifestyle factors. While moderate caffeine consumption may offer protective benefits against CVD, excessive intake poses arrhythmic risks, particularly in individuals with pre-existing conditions. Tailored recommendations considering sex-specific differences are essential for optimizing caffeine’s role in cardiovascular health and minimizing risks in older adults.